Long-term Outcome of End-stage Renal Disease Patients Treated With Hig-efficiency Hemodiafiltration
Long-term Outcome of End-stage Renal Disease Patients Treated With Hig-efficiency Hemodiafiltration
A retrospective cohort study was conducted in 66 end-stage renal disease patients who
 underwent high-efficiency hemodiafiltration technique in King Chulalongkorn Memorial Hospital
 between 2001-2013 to determine the survival rate as well as other long-term outcome.
Growing evidences suggested the superiority of high-efficiency hemodiafiltration (HDF) which
 could provide both diffusion and convection in a single therapy compared with the
 conventional hemodialysis. However, the long-term, upto 10 years, outcome still limited. This
 retrospective cohort study was conducted in 66 end-stage renal disease patients who underwent
 high-efficiency hemodiafiltration technique in a single-center, King Chulalongkorn Memorial
 Hospital, between 2001-2013 to determine the survival rate as well as other long-term outcome
Inclusion Criteria:

 -  Aged 18 years or more

 -  Be diagnosed end-stage renal disease for more than one year

 -  Have been regularly received long-term hemodiafiltration for more than 6 months.

 Exclusion Criteria:

 -  Patients who received hemodiafiltration less than 6 months